organoids

1.
Else Driehuis, Kai Kretzschmar, Hans Clevers. Establishment of patient-derived cancer organoids for drug-screening applications. Nature Protocols. 2020;15(10):3380-3409. doi:10.1038/s41596-020-0379-4
View Full Reference
1.
Kadi Lõhmussaar, Matteo Boretto, Hans Clevers. Human-Derived Model Systems in Gynecological Cancer Research. Trends in Cancer. 2020;6(12):1031-1043. doi:10.1016/j.trecan.2020.07.007
View Full Reference
1.
Yotam E. Bar-Ephraim, Kai Kretzschmar, Hans Clevers. Organoids in immunological research. Nature Reviews. Immunology. 2020;20(5):279-293. doi:10.1038/s41577-019-0248-y
View Full Reference
1.
Jennifer M. Rosenbluth, Ron C. J. Schackmann, G. Kenneth Gray, et al. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nature Communications. 2020;11(1):1711. doi:10.1038/s41467-020-15548-7
View Full Reference
1.
Frans Schutgens, Hans Clevers. Human Organoids: Tools for Understanding Biology and Treating Diseases. Annual Review of Pathology. 2020;15:211-234. doi:10.1146/annurev-pathmechdis-012419-032611
View Full Reference
1.
Frans Schutgens, Hans Clevers. Human Organoids: Tools for Understanding Biology and Treating Diseases. Annual Review of Pathology. 2020;15:211-234. doi:10.1146/annurev-pathmechdis-012419-032611
View Full Reference
1.
Fjodor A. Yousef Yengej, Jitske Jansen, Maarten B. Rookmaaker, Marianne C. Verhaar, Hans Clevers. Kidney Organoids and Tubuloids. Cells. 2020;9(6):1326. doi:10.3390/cells9061326
View Full Reference
1.
Uwe Marx, Takafumi Akabane, Tommy B. Andersson, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37(3):365-394. doi:10.14573/altex.2001241
View Full Reference
1.
Donald E. Ingber. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Advanced Science. 2020;7(22):2002030. doi:10.1002/advs.202002030
View Full Reference
1.
Vanessa Monteil, Hyesoo Kwon, Patricia Prado, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4):905-913.e7. doi:10.1016/j.cell.2020.04.004
View Full Reference